BioSpace News Archive

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update

Sernova Corp. today announced it will host two investor and analyst conference calls, with corresponding live webcasts.

September 13, 2023

·

5 min read

OnPoint Augmented Reality Spine System Accuracy Exceeds Major Existing Navigation, Robotic and AR System 2X-5X in Peer Reviewed Preclinical Studies

OnPoint Surgical, Inc. today announced that the accuracy of the OnPoint Augmented Reality Spine System has been reported in two separate presentations at the 2023 Congress of Neurological Surgeons, Sept. 9 – 13, in Washington, D.C.

September 13, 2023

·

4 min read

Business

Alex Gorsky Joins Neurotech’s Board as Lead Director

Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.

September 13, 2023

·

3 min read

Deals

Alnylam Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that NASDAQ has halted trading of the Company’s common stock.

September 13, 2023

·

9 min read

OneOncology and Its Practice Partners Celebrate Five Years of Cancer Care Excellence

OneOncology, the fastest growing national platform for independent oncology practices, and its practice partners, celebrate five years since creating the OneOncology partnership.

September 13, 2023

·

4 min read

BioForest

Adaptive Announces Launch of Epic Integration for clonoSEQ®The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood cancers

Adaptive Biotechnologies Corporation today announced that clonoSEQ ® is now available to health care providers as a fully integrated test in Aura, Epic’s specialty diagnostics suite.

September 13, 2023

·

6 min read

TerrAscend to Host 2023 Investor Day on October 13th at The Toronto Stock Exchange

TerrAscend Corp. today announced that it will host an Investor Day at the Toronto Stock Exchange (the “TSX”) in Toronto, Ontario, on Friday, October 13, 2023 from 9:30 a.m. to approximately 12:30 p.m. ET.

September 13, 2023

·

2 min read

Drug Development

Kyverna Therapeutics Announces Achievement of 28-Day Post-Infusion Milestone for First U.S. Patient Dosed in Phase 1 Clinical Trial of CD19 CAR T-Cell Therapy for Lupus Nephritis

Kyverna Therapeutics today announced that KYV-101 was generally well tolerated with no report of immune effector cell-associated neurotoxicity syndrome (ICANS) after the standard 28-day post infusion observation period of the first U.S. patient enrolled in its Phase 1 clinical trial in subjects with relapsed or refractory lupus nephritis (LN).

September 13, 2023

·

5 min read

Bio NC

Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023

Science 37 announced today that it has been recognized in the Gartner Hype Cycle for Life Science Clinical Development, 2023.

September 13, 2023

·

6 min read

FDA

Insight Medbotics Announces World’s First FDA-Cleared, MRI-Compatible Robot

Insight Medbotics today announced a successful 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IGAR system, the company’s MRI-compatible robot.

September 13, 2023

·

3 min read